Intralipid

Soya Oil, the active ingredient in Intralipid, is an intravenous lipid emulsion presented as an intravenous emulsion for intravenous use. It supplies calories and essential fatty acids to patients receiving total parenteral nutrition, helping to prevent essential fatty acid deficiency and support metabolic needs.

GNH USA supplies Intralipid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Intralipid is used in parenteral nutrition to provide essential fatty acids and calories.

Parenteral nutrition: provides calories and essential fatty acids for patients unable to receive enteral feeding. Essential fatty acid deficiency prevention: supplies linoleic acid to avoid deficiency during long‑term total parenteral nutrition. Neonatal nutrition support: delivers needed lipids to premature infants requiring parenteral nutrition.

Intralipid may cause a range of infusion‑related reactions.

Common Side Effects: - Fever or chills during infusion - Mild hypertriglyceridemia - Fat overload syndrome (elevated serum lipids) - Transient rash or urticaria - Elevated liver enzymes - Electrolyte shifts (e.g., hypophosphatemia)

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction - Severe hypertriglyceridemia leading to pancreatitis - Infection risk due to lipid medium supporting microbial growth - Pulmonary embolism from lipid particles - Metabolic acidosis in susceptible patients

When using Intralipid, clinicians should observe several safety measures.

Patient assessment: evaluate baseline triglyceride levels before initiation. Monitoring: regularly check serum triglycerides, liver function tests, and electrolytes during therapy. Compatibility: administer via a dedicated line; avoid mixing with incompatible solutions. Infusion rate: do not exceed recommended rates to prevent fat overload syndrome. Special populations: use caution in patients with disorders of lipid metabolism or severe hepatic impairment. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intralipid can interact with other medications that affect lipid metabolism or increase the risk of hypertriglyceridemia.

Major Interactions (Avoid): - Propofol: additive lipid load may cause severe hypertriglyceridemia. - Heparin: can increase lipolysis and alter triglyceride levels. - High‑dose corticosteroids: may exacerbate hypertriglyceridemia.

Moderate Interactions (Monitor Closely): - Cyclosporine: may raise serum lipid concentrations. - Estrogen therapy: can increase triglyceride levels. - Other components of total parenteral nutrition: avoid exceeding total lipid calorie limits.